AzTrials
AzTrials

Closed Fracture Proximal Humerus, NeckHURANCT00612391

Lateral Mini Approach vs Anterior Approach for Plating of Proximal Humerus Fracture

A study testing Lateral minimally invasive approach (plate fixation) and Deltopectoral approach (plate fixation) in people with Closed Fracture Proximal Humerus, Neck, run by Université de Montréal at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective randomized clinical trial is proposed to compare the plate fixation of proximal humerus fractures using a minimally invasive lateral approach and the traditional anterior approach.Forty five patients will be assigned to each approach (total of 90 patients) and will be assessed 7 times over a two-year… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Closed Fracture Proximal Humerus, Neck
What is being tested?
Lateral minimally invasive approach (plate fixation) and Deltopectoral approach (plate fixation)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
79 participants
Where
1 siteCanada
Study dates
Nov 2007to Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Humeral surgical neck fracture, Neer II valgus-type Neer III
  • Patient willing to participate in the study
  • Patient available for follow-up through at least two years
  • Patient with acceptable preoperative medical clearance and free of, or treated for, medical conditions that would pose excessive operative risk
  • Patient fluent in French and/or English and able to understand his/her role in the study

Who cannot join

  • Inflammatory arthritis
  • Prior shoulder pathology
  • Active local or systemic infection
  • Neurologic or musculoskeletal disease that may adversely affect mobility
  • Participation in any other pharmaceutical, biologic or medical-device clinical investigation
  • Severe documented psychiatric disease
  • Severe ipsilateral elbow or wrist disease
  • Fracture resistant to reduction attempts through the minimally invasive lateral approach

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Hopital Sacré-Coeur

    Montreal, Quebec, H4J1C5

Other trials in Canada

About this study

Official title: A Randomized Clinical Trail Comparing a Lateral Minimally Invasive Approach and the Traditional Anterior Approach for Plating of Proximal Humerus Fractures

A prospective randomized clinical trial is proposed to compare the plate fixation of proximal humerus fractures using a minimally invasive lateral approach and the traditional anterior approach.Forty five patients will be assigned to each approach (total of 90 patients) and will be assessed 7 times over a two-year period. The trial's primary objectives will be to demonstrate the efficacy of the plating technique in terms of speed of recuperation of function. The Quick DASH will be used for evaluation of function.The study will also examine secondary end-points of pain, range of motion, esthetic satisfaction and radiographic outcome, as assessed by the components of the Constant Score3,4, SF-12V2 Questionnaire, and Patient Scare Assessment Scale Questionnaire. Furthermore, the assessment of safety will be based on the rates of all reported complications and adverse events at 2 years

Being tested
Lateral minimally invasive approach (plate fixation), Deltopectoral approach (plate fixation)
Keywords
humerus fracture
Medical subject headings
Humeral Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lateral minimally invasive approach (plate fixation)Procedure or surgery

    A longitudinally oriented, 4-cm incision will be made laterally starting at the acromion. The deltoid will be split proximally at the most strategic location (vis-à-vis the fracture), and after the deltoid is bluntly elevated from the humerus more distally the axillary nerve will be identified by digital palpation. The nerve is easily identified posteriorly as it emerges from the quadrilateral space. With a finger maintained on the nerve for protection, the plate will be inserted onto the lateral side of the proximal humerus and fixed according to the described technique. A second, 2-cm longitudinal incision will then be made further distally for diaphyseal screw placement. This incision is well distal to the course of the axillary nerve.

  • Deltopectoral approach (plate fixation)Procedure or surgery

    Anterior, Delto-Pectoral Approach - A 10-cm incision will be made over the deltopectoral groove, starting at the coracoid process proximally. As the clavipectoral fascia is incised, the cephalic vein will be identified and retracted laterally with the deltoid muscle. The pectoralis major as well as the conjoint tendon will be retracted medially, and the long head of the biceps tendon will be identified and used as a guide for achieving an anatomic reduction of the different fracture parts. Next, internally rotating the humerus will allow access to the lateral side of the proximal humerus, on which the plate will then be fixed according to the described technique.

Study groups in NCT00612391
Study groupRoleWhat they receive
Lateral, Minimally Invasive ApproachExperimentalLateral, Minimally Invasive Approach in GT fractures treated operatively (plates and screws)
Receives: Procedure: Lateral minimally invasive approach (plate fixation)
Deltopectoral approach:Active comparatorDeltopectoral approach for GT fracture treated operatively
Receives: Procedure: Deltopectoral approach (plate fixation)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quick DASH

    Measured: 3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.

Secondary outcomes (1)
  1. SF-12V2 Questionnaire Constant Shoulder Score The Patient Scar Assessment Scale Complication rate

    Measured: 3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2008 (estimated)
  2. Study startNov 2007
  3. Primary completionJul 2019
  4. Study completionNov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
79 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00612391
Sponsor's protocol ID
HURA1
Acronym
HURA
Status last verified
Apr 2021
First submitted
29 Jan 2008
Last updated
30 Apr 2021
Results posted
No
Data monitoring committee
No

Publications

  • Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.

    PubMed 35727196

Questions about this trial

What is this clinical trial studying?

A study testing Lateral minimally invasive approach (plate fixation) and Deltopectoral approach (plate fixation) in people with Closed Fracture Proximal Humerus, Neck, run by Université de Montréal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quick DASH (time frame: 3, 6, and 12 weeks, and at 6, 12, 18 and 24 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00612391, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in